Artivion reported $363.79M in Loan Capital for its fiscal quarter ending in September of 2026.





Loan Capital Change Date
Abbott USD 29.45B 152M Sep/2026
Accuray USD 124.78M 2.54M Dec/2025
AngioDynamics USD 5.6M 100K Sep/2025
Artivion USD 363.79M 364K Sep/2026
AtriCure USD 61M 0 Sep/2026
Baxter International USD 8.62B 6M Jun/2026
Becton, Dickinson and Co. USD 13.42B 89M Sep/2026
Boston Scientific USD 10.79B 73M Jun/2026
Edwards Lifesciences USD 598.8M 100K Sep/2026
Inogen USD 0 0 Jun/2022
Integra LifeSciences USD 1.83B 2.12M Sep/2026
J&J USD 35.8B 1.55B Sep/2026
Mesa Laboratories USD 104.2M 104.3M Sep/2024
Orthofix International USD 221.85M 256K Sep/2026
Pfizer USD 60B 498M Sep/2026
ResMed USD 399.42M 4.75M Jun/2026
Stryker USD 14.18B 16M Sep/2026
Tandem Diabetes Care USD 603.39M 811K Sep/2026
Teleflex USD 1.53B 1.19B Sep/2026
Terumo JPY 246.97B 37.45B Sep/2026
Trinity Biotech USD 26.69M 10.36M Mar/2026